Kaiser Peterinsider trades

In SEC Form 4 filings, Kaiser Peter is listed as Chief Development Officer of Ocular Therapeutix, Inc (OCUL). In the last 90 days, Kaiser Peter sold $103.1K of Ocular Therapeutix, Inc (OCUL) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
OCULOcular Therapeutix, Inc	Chief Development Officer	2	Oct 6

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-26

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
OCULOcular Therapeutix, Inc	Oct 2	Oct 6	S	9,990	$7.05	Sale −$70,430	254,388	Yes	Form 4
OCULOcular Therapeutix, Inc	Aug 24	Aug 26	S	3,035	$10.77	Sale −$32,687	264,378	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.